Augmentation of plasminogen activator inhibitor type 1 activity in plasma by thrombosis and by thrombolysis

This publication has 32 references indexed in Scilit:

• Mechanism of action of heparin and anticoagulant therapy
  Coronary Artery Disease, 1990
• Potential attenuation of fibrinolysis by growth factors released from platelets and their pharmacologic implications
  The American Journal of Cardiology, 1989
• Whole blood platelet function in acute ischemic stroke. Importance of dense body secretion and effects of antithrombotic agents.
  Stroke, 1989
• PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION
  The Lancet, 1987
• Platelet Activation in Unstable Coronary Disease
  New England Journal of Medicine, 1986
• The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma
  Scandinavian Journal of Clinical and Laboratory Investigation, 1985
• Coronary thrombolysis with intravenously administered human tissue-type plasminogen activator produced by recombinant DNA technology.
  Circulation, 1984
• A study of proteases and protease-inhibitor complexes in biological fluids
  The Journal of Experimental Medicine, 1978
• Platelet aggregation in partially obstructed vessels and its elimination with aspirin.
  Circulation, 1976
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
  Nature, 1970